Simpson Thacher & Bartlett is representing Karuna Therapeutics, Inc. in the transaction. Bristol-Myers Squibb Company (“BMS”, NYSE: BMY) announced its acquisition of Karuna Therapeutics, Inc. (“Karuna”) for $330...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here